Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) — Capital Reinvestment Ratio
Starlake Bioscience Co Inc Zhaoqing Guangdong (600866) has a Capital Reinvestment Ratio of 0.52x as of September 2025, meaning it reinvests 1% of its operating cash flow (CN¥1.25 Billion) in capital expenditures (CN¥652.49 Million). See free cash flow generation of Starlake Bioscience Co Inc Zhaoqing Guan to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Starlake Bioscience Co Inc Zhaoqing Guangdong Capital Reinvestment Ratio (1998–2025)
This chart tracks Starlake Bioscience Co Inc Zhaoqing Guangdong's Capital Reinvestment Ratio across 25 annual periods.
Annual Capital Reinvestment Ratio for Starlake Bioscience Co Inc Zhaoqing Guangdong (1998–2025)
Year-by-year Capital Reinvestment Ratio for Starlake Bioscience Co Inc Zhaoqing Guangdong from 1998 to 2025. For live market cap and broader valuation context, see Starlake Bioscience Co Inc Zhaoqing Guan (600866) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 1.58x | CN¥1.29 Billion | CN¥2.04 Billion | ▲ +492.5% |
| 2024 | 0.27x | CN¥2.40 Billion | CN¥638.50 Million | ▲ +43.6% |
| 2023 | 0.19x | CN¥2.03 Billion | CN¥375.83 Million | ▼ -31.8% |
| 2022 | 0.27x | CN¥1.66 Billion | CN¥452.34 Million | ▼ -74.4% |
| 2021 | 1.06x | CN¥192.63 Million | CN¥205.08 Million | ▼ -8.2% |
| 2020 | 1.16x | CN¥249.99 Million | CN¥289.89 Million | ▲ +57.0% |
| 2019 | 0.74x | CN¥213.17 Million | CN¥157.41 Million | ▲ +11.0% |
| 2018 | 0.67x | CN¥50.69 Million | CN¥33.71 Million | ▼ -34.4% |
| 2017 | 1.01x | CN¥40.05 Million | CN¥40.61 Million | ▲ +3.7% |
| 2016 | 0.98x | CN¥41.17 Million | CN¥40.26 Million | ▼ -97.4% |
| 2015 | 37.70x | CN¥2.75 Million | CN¥103.49 Million | ▲ +189.0% |
| 2011 | 13.05x | CN¥65.88 Million | CN¥859.52 Million | ▲ +244.3% |
| 2010 | 3.79x | CN¥104.63 Million | CN¥396.40 Million | ▲ +1816.9% |
| 2009 | 0.20x | CN¥316.73 Million | CN¥62.60 Million | ▼ -41.1% |
| 2008 | 0.34x | CN¥148.93 Million | CN¥49.97 Million | ▼ -63.1% |
| 2007 | 0.91x | CN¥82.28 Million | CN¥74.90 Million | ▼ -58.6% |
| 2006 | 2.20x | CN¥35.14 Million | CN¥77.37 Million | ▲ +47.8% |
| 2005 | 1.49x | CN¥46.83 Million | CN¥69.77 Million | ▼ -80.4% |
| 2004 | 7.60x | CN¥29.05 Million | CN¥220.76 Million | ▲ +932.9% |
| 2003 | 0.74x | CN¥149.70 Million | CN¥110.12 Million | ▲ +52.8% |
| 2002 | 0.48x | CN¥183.18 Million | CN¥88.18 Million | ▼ -62.1% |
| 2001 | 1.27x | CN¥60.82 Million | CN¥77.35 Million | ▲ +76.9% |
| 2000 | 0.72x | CN¥93.41 Million | CN¥67.16 Million | ▼ -52.1% |
| 1999 | 1.50x | CN¥52.97 Million | CN¥79.45 Million | ▼ -6.2% |
| 1998 | 1.60x | CN¥71.14 Million | CN¥113.73 Million | — |